He leads with heart and hustle at Groote Schuur but money is a big problem, says nursing boss

He leads with heart and hustle at Groote Schuur but money is a big problem, says nursing boss

Groote Schuur Hospital’s first male nursing manager, Aghmat Mohamed, reflects on the pressures of nursing in South Africa. Ahead of International Nurses Day and the release of a major global report on the state of nursing, Biénne Huisman chatted to him about his decades on the front lines of healthcare.

Read More

Rates of obesity are soaring worldwide: Have we been misunderstanding the problem?

Rates of obesity are soaring worldwide: Have we been misunderstanding the problem?

Authors of a recent Lancet report argue that obesity should not just be seen as a risk factor for other diseases – but in some cases, should be seen as a disease itself. The position could change how we treat obesity globally. In the first of this two-part Spotlight series, Jesse Copelyn breaks down the debate around the issue, and its implications for health policy.

Read More

Why some babies in South Africa are still getting HIV

Why some babies in South Africa are still getting HIV

Over the last two decades, South Africa made massive progress in reducing transmission of HIV from mothers to their babies. Even so, about 7 000 babies still contract the virus every year. Experts put this down to having the right puzzle pieces for prevention but failing to integrate them optimally. Elna Schütz reports.

Read More

#Health4Sale | Tribunal orders controversial ambulance companies to pay back over half-a-billion rand

#Health4Sale | Tribunal orders controversial ambulance companies to pay back over half-a-billion rand

The Special Tribunal has ordered four ambulance companies run by Thapelo Buthelezi to pay back a total of over half-a-billion rand. The matter relates to contracts awarded by the Free State government, which were first reported on in Spotlight’s #Health4Sale series of investigative articles in 2018.

Read More

Inside The Box with Dr Andy Gray | Are clinical trial participants in South Africa protected?

Inside The Box with Dr Andy Gray | Are clinical trial participants in South Africa protected?

Clinical trial participants appear to be well protected in South Africa, particularly as the country’s guidelines recognise the risks of research with international collaborators. The sudden end of US-funded clinical trials, however, is exposing some limitations of ethics codes and guidelines, argues Dr Andy Gray.

Read More

US pulls funding for South African medical research

US pulls funding for South African medical research

US funding for clinical research in South Africa is incrementally being cancelled. This is happening through at least two processes – the first is by banning certain kinds of foreign grants called sub-awards (which is affecting everyone globally). The second is by failing to issue routine renewals of grants for clinical studies in South Africa. Spotlight and GroundUp break down the current situation.

Read More

Gauteng state doctors gear up to fight health department over overtime payments

Gauteng state doctors gear up to fight health department over overtime payments

Trade unions, medical associations and universities are raising the alarm that Gauteng budget cuts at the cost of doctors’ take-home pay will have dire consequences for public sector health. Meanwhile, the National Minister of Health has convened a committee to review the future of overtime for state doctors. Ufrieda Ho reports.

Read More

Large numbers of TB survivors in SA struggling with lung damage, experts say

Large numbers of TB survivors in SA struggling with lung damage, experts say

There are over three million people alive in South Africa who have been cured of TB. But even after being cured, many continue to suffer the long-term after-effects of the disease. To find out more about this under-recognised problem, Spotlight recently attended a global gathering of experts focused on life after TB.

Read More

Cape Town study brings hope to newborns left behind in HIV treatment advances

Cape Town study brings hope to newborns left behind in HIV treatment advances

Research led by Professor Adrie Bekker is paving the way for an important HIV medicine to be made available to neonates in a way that is both safe and much more convenient than previous options. Biénne Huisman met with the passionate clinician-scientist at her office in Cape Town.

Read More

Antibiotic resistance is putting SA’s newborns at risk

Antibiotic resistance is putting SA’s newborns at risk

Experts say bacterial infections are responsible for more infant deaths than is generally recognised, and things may get worse as more of the bugs become resistant to commonly used antibiotics. Sue Segar asked local experts about this growing threat to newborns.

Read More

How an SAMRC study found that HIV deaths in SA may be massively undercounted

How an SAMRC study found that HIV deaths in SA may be massively undercounted

It is widely acknowledged among health and demographic experts that relying solely on what is written on death certificates does not paint an accurate picture of what people in South Africa are actually dying of. Now, an SAMRC study has provided evidence that the undercounting of deaths due to HIV might be even greater than previously thought. Chris Bateman reports.

Read More

Francois Venter | Our HIV programme is collapsing — and our government is nowhere to be seen

Francois Venter | Our HIV programme is collapsing — and our government is nowhere to be seen

We’re watching the largest HIV treatment programme in the world unravelling in real time. We don’t need perfection, but we do need a combination of urgency, action, and strategy to save it, argues Professor Francois Venter.

Read More